- Home
- ONC
as 06-20-2025 4:00pm EST
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.
| Founded: | 2010 | Country: | Switzerland |
| Employees: | N/A | City: | GRAND CAYMAN |
| Market Cap: | 26.9B | IPO Year: | N/A |
| Target Price: | $326.43 | AVG Volume (30 days): | 314.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.70 | EPS Growth: | N/A |
| 52 Week Low/High: | $141.31 - $287.88 | Next Earning Date: | 08-06-2025 |
| Revenue: | $4,175,868,000 | Revenue Growth: | 51.16% |
| Revenue Growth (this year): | 869.15% | Revenue Growth (next year): | 19.07% |
Latest BeiGene Ltd. American Depositary Shares News
ONC Breaking Stock News: Dive into ONC Ticker-Specific Updates for Smart Investing
Business Wire
9 days ago
BeOne Medicines Showcases Breakthrough Data in CLL and MCL at EHA 2025
Business Wire
10 days ago
U.S. FDA Approves Tablet Formulation of BeOne’s BRUKINSA® for All Approved Indications
Business Wire
10 days ago
BeOne Medicines to Host Investor R&D Day Webcast on June 26, 2025
Simply Wall St.
12 days ago
BeOne Medicines And 2 Stocks That May Be Undervalued By The Market
Investor's Business Daily
16 days ago
Cancer Stock Vaults 40% As Clinical Trial Shows 'Promise'; Sales Reach $1 Billion, Earnings To Triple
Business Wire
19 days ago
BeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 2025
Business Wire
21 days ago
BeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA’s Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 2025
MT Newswires
25 days ago
Sector Update: Health Care Stocks Rise Premarket Tuesday
Compare ONC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ONC BeiGene Ltd. American Depositary Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.